Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke

Conditions: Ischemic Stroke Interventions: Drug: Rivaroxaban 2.5 Mg Oral Tablet; Drug: Colchicine 0.5 MG; Drug: Placebo Rivaroxaban; Drug: Placebo Colchicine Sponsors: Brazilian Clinical Research Institute; Allian ça Diagnostic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials